Global Electronic Drug Delivery System Market Size To Worth USD 17.77 Billion By 2033 | CAGR Of 5.58%
Category: HealthcareGlobal Electronic Drug Delivery System Market Size To Worth USD 17.77 Billion By 2033
According to a research report published by Spherical Insights & Consulting, The Global Electronic Drug Delivery System Market Size is to Grow from USD 10.32 Billion in 2023 to USD 17.77 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.58% during the projected period.
Get more details on this report -
Browse key industry insights spread across 240 pages with 110 Market data tables and figures & charts from the report on the "Global Electronic Drug Delivery System Market Size, Share, and COVID-19 Impact Analysis, By Type (Wearable Infusion Pumps, Implantable Infusion Pumps, Auto-Injectors, Pen Injectors, Inhalers), By Technology (Micro-Electromechanical Systems (MEMS), Battery-Powered Systems, Piezoelectric Systems), By Application (Diabetes Management, Pain Management, Cardiovascular Disorders, Cancer Treatment, Hormone Therapy, Neurological Disorders), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/electronic-drug-delivery-system-market
Electronic drug delivery systems (EDDS) are sophisticated medicine administration techniques that employ electronic devices to manage timing, dose, and release. These systems improve precision and flexibility by using technology such as microprocessors, sensors, and wireless communication. They provide various benefits, including precise control over medication distribution, fewer dose mistakes, better treatment results, and real-time patient data modification. EDDS can also offer patients feedback on their drug use and modify doses depending on physiological changes, resulting in more individualized treatment. Furthermore, EDDS reduces the need for manual administration, boosting convenience while decreasing human error. However, electronic drug delivery systems can be complex and costly, which may limit their accessibility for some patients. The initial expense for both the devices and their maintenance can be high, and there may be additional costs associated with training healthcare providers and patients on their use.
The wearable infusion pump segment is anticipated to hold the greatest share of the global electronic drug delivery system market during the projected timeframe.
Based on the type, the global electronic drug delivery system market is divided into wearable infusion pumps, implantable infusion pumps, auto-injectors, pen injectors, and inhalers. Among these, the wearable infusion pumps segment is anticipated to hold the greatest share of the global electronic drug delivery system market during the projected timeframe. Wearable infusion pumps are gaining popularity due to their convenience, reduced manual interventions, and enhanced patient compliance, with advancements in technology promoting home-based healthcare and remote patient monitoring.
The micro-electromechanical systems (MEMS) segment is anticipated to grow at the fastest pace in the global electronic drug delivery system market during the projected timeframe.
Based on the technology, the global electronic drug delivery system market is divided into micro-electromechanical systems (MEMS), battery-powered systems, and piezoelectric systems. Among these, the solar photovoltaic system segment is anticipated to grow at the fastest pace in the global electronic drug delivery system market during the projected timeframe. MEMS technology enhances medication delivery dependability, integration, and compactness, making it suited for insulin pumps and implantable devices, owing to the growing demand for efficient, tailored solutions.
The diabetes management segment is anticipated to grow at the fastest pace in the global electronic drug delivery system market during the projected timeframe.
Based on the application, the global electronic drug delivery system market is divided into diabetes management, pain management, cardiovascular disorders, cancer treatment, hormone therapy, and neurological disorders. Among these, the solar photovoltaic system segment is anticipated to grow at the fastest pace in the global electronic drug delivery system market during the projected timeframe. Diabetes management is expected to expand due to global prevalence, continuous glucose monitoring, and personalized medicine, enhancing efficiency and user-friendliness in diabetes management.
North America is expected to hold the largest share of the global electronic drug delivery system market over the forecast period.
Get more details on this report -
North America is expected to hold the largest share of the global electronic drug delivery system market over the forecast period. The United States dominates the electronic drug delivery system market because of sophisticated infrastructure, new medical technology, and research investments backed by prominent pharmaceutical corporations.
Asia Pacific is predicted to grow at the fastest pace in the global electronic drug delivery system market during the projected timeframe. The region is growing rapidly as a result of an increasing patient population, chronic illness prevalence, and increased healthcare spending, all of which are being pushed by infrastructure and technology expenditures.
Major vendors in the Global Electronic drug delivery system Market include Medtronic, Insulet Corporation, Roche, BD (Becton, Dickinson, and Company), Abbott Laboratories, Johnson & Johnson, Novo Nordisk, Baxter International, Tandem Diabetes Care, Ypsomed, Smiths Medical, Zogenix, Valeritas, Senseonics, Dexcom, and Others.
Recent Developments
- In March 2023, Abbott received FDA clearance for its FreeStyle Libre 2 and FreeStyle Libre 3 integrated continuous glucose monitoring system sensors for integration with automated insulin delivery systems.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Electronic Drug Delivery System Market based on the below-mentioned segments:
Global Electronic Drug Delivery System Market, By Product
- Wearable Infusion Pumps
- Implantable Infusion Pumps
- Autoinjectors
- Pen Injectors
- Inhalers
Global Electronic Drug Delivery System Market, By Technology
- Micro-Electromechanical Systems (MEMS)
- Battery-Powered Systems
- Piezoelectric Systems
Global Electronic Drug Delivery System Market, By Application
- Diabetes Management
- Pain Management
- Cardiovascular Disorders
- Cancer Treatment
- Hormone Therapy
- Neurological Disorders
Global Electronic Drug Delivery System Market, Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?